Lista de obras -

A new MALDI-TOF-based assay for monitoring JAK2 V617F mutation level in patients undergoing allogeneic stem cell transplantation (allo SCT) for classic myeloproliferative disorders (MPD).

artículo científico publicado en 2007

A randomized controlled multicenter study comparing recombinant interleukin 2 (rIL-2) in conjunction with recombinant interferon alpha (IFN-alpha) versus no immunotherapy for patients with malignant lymphoma postautologous stem cell transplantation

artículo científico publicado en 2010

Allogeneic hematopoietic stem-cell transplantation for acute myeloid leukemia in remission: comparison of intravenous busulfan plus cyclophosphamide (Cy) versus total-body irradiation plus Cy as conditioning regimen--a report from the acute leukemia

artículo científico publicado en 2013

Allogeneic stem cell transplantation and targeted immunotherapy for multiple myeloma

artículo científico publicado en 2013

Allogenic hematopoietic stem-cell transplantation with reduced-intensity conditioning in patients with refractory and recurrent multiple myeloma: long-term follow-up

artículo científico publicado en 2010

Apoptotic cells in allogeneic hematopoietic stem cell transplantations: “turning trash into gold” ⬇️

artículo científico publicado el 1 de noviembre de 2012

BCL6 is regulated by p53 through a response element frequently disrupted in B-cell non-Hodgkin lymphoma.

artículo científico publicado en 2005

BL-8040 CXCR4 antagonist is safe and demonstrates antileukemic activity in combination with cytarabine for the treatment of relapsed/refractory acute myelogenous leukemia: An open-label safety and efficacy phase 2a study

scientific article published on 03 December 2020

Carfilzomib combined with cyclosporine and methotrexate for the prevention of graft-versus-host disease after allogeneic stem-cell transplantation from unrelated donors

artículo científico publicado en 2020

Changes in gene expression pattern following granulocyte colony-stimulating factor administration to normal stem cell sibling donors

artículo científico publicado en 2006

Characterization of cyclin E expression in multiple myeloma and its functional role in seliciclib-induced apoptotic cell death

artículo científico publicado en 2012

Chemotherapy dose adjustment for obese patients undergoing hematopoietic stem cell transplantation: a survey on behalf of the Acute Leukemia Working Party of the European Society for Blood and Marrow Transplantation

artículo científico publicado en 2014

Clinical impact of human Jurkat T-cell-line-derived antithymocyte globulin in multiple myeloma patients undergoing allogeneic stem cell transplantation

artículo científico publicado en 2008

Clinical implications of minimal residual disease monitoring for stem cell transplantation after reduced intensity and nonmyeloablative conditioning

artículo científico publicado en 2004

Clinical responses in a phase II study using adoptive transfer of short-term cultured tumor infiltration lymphocytes in metastatic melanoma patients

artículo científico publicado en 2010

Cord blood stem cells for hematopoietic transplantation

artículo científico publicado el 1 de junio de 2011

Cytomegalovirus retinitis in HIV-negative patients: a practical management approach

artículo científico publicado en 2014

Determination of chromosome 13 status in bone marrow cells of patients with multiple myeloma using combined morphologic and fluorescence in situ hybridization analysis

artículo científico publicado en 2004

Double umbilical cord blood transplant: more than a cell dose?

scientific article published on June 2010

Fludarabine and treosulfan: a novel modified myeloablative regimen for allogeneic hematopoietic stem-cell transplantation with effective antileukemia activity in patients with acute myeloid leukemia and myelodysplastic syndromes

artículo científico publicado en 2007

Fludarabine, cyclophosphamide, antithymocyte globulin, with or without low dose total body irradiation, for alternative donor transplants, in acquired severe aplastic anemia: a retrospective study from the EBMT-SAA Working Party

artículo científico publicado en 2010

Genetic variations in the heparanase gene (HPSE) associate with increased risk of GVHD following allogeneic stem cell transplantation: effect of discrepancy between recipients and donors

artículo científico publicado en 2010

Granulocyte-colony stimulating factor for hematopoietic stem cell donation from healthy female donors during pregnancy and lactation: what do we know? ⬇️

artículo científico publicado el 3 de enero de 2013

High response rate and improved graft-versus-host disease following bortezomib as salvage therapy after reduced intensity conditioning allogeneic stem cell transplantation for multiple myeloma

artículo científico publicado en 2008

Human cytomegalovirus kinetics following institution of artesunate after hematopoietic stem cell transplantation.

artículo científico publicado en 2011

Immunological effects of nilotinib prophylaxis after allogeneic stem cell transplantation in patients with advanced chronic myeloid leukemia or philadelphia chromosome-positive acute lymphoblastic leukemia

artículo científico publicado en 2016

Inhibition of matrix metalloproteinase-2 by halofuginone is mediated by the Egr1 transcription factor

artículo científico publicado en 2012

Intravenous busulfan for autologous stem cell transplantation in adult patients with acute myeloid leukemia: a survey of 952 patients on behalf of the Acute Leukemia Working Party of the European Group for Blood and Marrow Transplantation.

artículo científico publicado en 2014

Intravenous busulfan-based conditioning prior to allogeneic hematopoietic stem cell transplantation: myeloablation with reduced toxicity

artículo científico publicado en 2003

Long-term outcome after a treosulfan-based conditioning regimen for patients with acute myeloid leukemia: A report from the Acute Leukemia Working Party of the European Society for Blood and Marrow Transplantation.

artículo científico publicado en 2017

Minimally cultured or selected autologous tumor-infiltrating lymphocytes after a lympho-depleting chemotherapy regimen in metastatic melanoma patients

artículo científico publicado en 2009

Missing HLA C group 1 ligand in patients with AML and MDS is associated with reduced risk of relapse and better survival after allogeneic stem cell transplantation with fludarabine and treosulfan reduced toxicity conditioning.

artículo científico publicado en 2017

Mobilization regimens prior to stem-cell collection in patients with lymphoma: how to choose?

artículo científico publicado en 2007

Modification of heparanase gene expression in response to conditioning and LPS treatment: strong correlation to rs4693608 SNP ⬇️

artículo científico publicado el 6 de diciembre de 2013

Monoclonal Antibody-Based Immunotherapy for Multiple Myeloma ⬇️

artículo científico publicado el 1 de septiembre de 2012

Non-myeloablative hematopoietic stem cell transplantation (NST) in the treatment of human malignancies: from animal models to clinical practice

artículo científico publicado en 2002

Non-myeloablative stem-cell transplantation in the treatment of malignant and non-malignant disorders.

artículo científico publicado en 2002

Nonmyeloablative stem cell transplantation: lessons from the first decade of clinical experience.

artículo científico publicado en 2004

Novel Immunosuppression Compounds and Experimental Therapies for Chronic Graft-Versus-Host Disease ⬇️

artículo científico publicado el 7 de febrero de 2013

Novel Strategies for Immunotherapy in Multiple Myeloma: Previous Experience and Future Directions ⬇️

artículo científico publicado el 10 de mayo de 2012

Optimizing the conditioning regimen for allogeneic stem-cell transplantation in acute myeloid leukemia; dose intensity is still in need ⬇️

artículo científico publicado el 24 de junio de 2011

Phase I safety and pharmacokinetic study of CT-011, a humanized antibody interacting with PD-1, in patients with advanced hematologic malignancies

artículo científico publicado en 2008

Prediction of Allogeneic Hematopoietic Stem-Cell Transplantation Mortality 100 Days After Transplantation Using a Machine Learning Algorithm: A European Group for Blood and Marrow Transplantation Acute Leukemia Working Party Retrospective Data [...]

artículo científico publicado en 2015

Prediction of Hematopoietic Stem Cell Transplantation Related Mortality- Lessons Learned from the In-Silico Approach: A European Society for Blood and Marrow Transplantation Acute Leukemia Working Party Data Mining Study

artículo científico publicado en 2016

Prospective noninterventional study on peripheral blood stem cell mobilization in patients with relapsed lymphomas

artículo científico publicado en 2016

Radioimmunotherapy and Autologous Stem-Cell Transplantation in the Treatment of B-Cell Non-Hodgkin Lymphoma

artículo científico publicado en 2016

Radioimmunotherapy and stem-cell transplantation in the treatment of aggressive B-cell lymphoma

artículo científico publicado en 2007

Reassessing the role of high dose cytarabine and mitoxantrone in relapsed/refractory acute myeloid leukemia

artículo científico publicado en 2020

Recent compounds for immunosuppression and experimental therapies for acute graft-versus-host disease

artículo científico publicado el 1 de enero de 2013

Regulatory T Cells in Allogeneic Stem Cell Transplantation ⬇️

artículo científico publicado el 8 de mayo de 2013

Rituximab reduces relapse risk after allogeneic and autologous stem cell transplantation in patients with high-risk aggressive non-Hodgkin's lymphoma

scientific article published on 01 August 2003

Salvage therapy with ARA-C and gemtuzumab ozogamicin in AML patients relapsing after stem cell transplantation

artículo científico publicado en 2014

Second allogeneic stem cell transplantation in patients with acute lymphoblastic leukaemia: a study on behalf of the Acute Leukaemia Working Party of the European Society for Blood and Marrow Transplantation.

artículo científico publicado en 2019

The High-Affinity CXCR4 Antagonist BKT140 Is Safe and Induces a Robust Mobilization of Human CD34+ Cells in Patients with Multiple Myeloma ⬇️

artículo científico publicado el 18 de noviembre de 2013

The combination of cyclosporine and mycophenolate mofetil is less effective than cyclosporine and methotrexate in the prevention of acute graft-versus host disease after stem-cell transplantation from unrelated donors.

artículo científico publicado en 2017

The expanding horizon of immunotherapy in the treatment of malignant disorders: allogeneic hematopoietic stem cell transplantation and beyond.

artículo científico publicado en 2014

The impact of graft-versus-host disease prophylaxis in reduced-intensity conditioning allogeneic stem cell transplant in acute myeloid leukemia: a study from the Acute Leukemia Working Party of the European Group for Blood and Marrow Transplantation

artículo científico publicado en 2015

The role of stem-cell transplantation in the treatment of marginal zone lymphoma

artículo científico publicado en 2016

Thiotepa-busulfan-fludarabine compared to busulfan-fludarabine for sibling and unrelated donor transplant in acute myeloid leukemia in first remission.

artículo científico publicado en 2017

Thrombotic microangiopathy after allogeneic stem cell transplantation in the era of reduced-intensity conditioning: The incidence is not reduced

artículo científico publicado en 2004

Treatment of severe steroid resistant acute GVHD with mesenchymal stromal cells (MSC) ⬇️

artículo científico publicado el 19 de agosto de 2013

Treatment with interferon alpha prior to discontinuation of imatinib in patients with chronic myeloid leukemia

artículo científico publicado en 2011

Tumor cell contamination in re-infused stem cell autografts: does it have clinical significance?

artículo científico publicado en 2002

Yttrium-90-ibritumomab tiuxetan (Zevalin) combined with high-dose BEAM chemotherapy and autologous stem cell transplantation for chemo-refractory aggressive non-Hodgkin's lymphoma

artículo científico publicado en 2007

Lista de obras de

A new MALDI-TOF-based assay for monitoring JAK2 V617F mutation level in patients undergoing allogeneic stem cell transplantation (allo SCT) for classic myeloproliferative disorders (MPD).

A randomized controlled multicenter study comparing recombinant interleukin 2 (rIL-2) in conjunction with recombinant interferon alpha (IFN-alpha) versus no immunotherapy for patients with malignant lymphoma postautologous stem cell transplantation

Allogeneic hematopoietic stem-cell transplantation for acute myeloid leukemia in remission: comparison of intravenous busulfan plus cyclophosphamide (Cy) versus total-body irradiation plus Cy as conditioning regimen--a report from the acute leukemia

Allogeneic stem cell transplantation and targeted immunotherapy for multiple myeloma

Allogenic hematopoietic stem-cell transplantation with reduced-intensity conditioning in patients with refractory and recurrent multiple myeloma: long-term follow-up

Apoptotic cells in allogeneic hematopoietic stem cell transplantations: “turning trash into gold” ⬇️

BCL6 is regulated by p53 through a response element frequently disrupted in B-cell non-Hodgkin lymphoma.

BL-8040 CXCR4 antagonist is safe and demonstrates antileukemic activity in combination with cytarabine for the treatment of relapsed/refractory acute myelogenous leukemia: An open-label safety and efficacy phase 2a study

Carfilzomib combined with cyclosporine and methotrexate for the prevention of graft-versus-host disease after allogeneic stem-cell transplantation from unrelated donors

Changes in gene expression pattern following granulocyte colony-stimulating factor administration to normal stem cell sibling donors

Characterization of cyclin E expression in multiple myeloma and its functional role in seliciclib-induced apoptotic cell death

Chemotherapy dose adjustment for obese patients undergoing hematopoietic stem cell transplantation: a survey on behalf of the Acute Leukemia Working Party of the European Society for Blood and Marrow Transplantation

Clinical impact of human Jurkat T-cell-line-derived antithymocyte globulin in multiple myeloma patients undergoing allogeneic stem cell transplantation

Clinical implications of minimal residual disease monitoring for stem cell transplantation after reduced intensity and nonmyeloablative conditioning

Clinical responses in a phase II study using adoptive transfer of short-term cultured tumor infiltration lymphocytes in metastatic melanoma patients

Cord blood stem cells for hematopoietic transplantation

Cytomegalovirus retinitis in HIV-negative patients: a practical management approach

Determination of chromosome 13 status in bone marrow cells of patients with multiple myeloma using combined morphologic and fluorescence in situ hybridization analysis

Double umbilical cord blood transplant: more than a cell dose?

Fludarabine and treosulfan: a novel modified myeloablative regimen for allogeneic hematopoietic stem-cell transplantation with effective antileukemia activity in patients with acute myeloid leukemia and myelodysplastic syndromes

Fludarabine, cyclophosphamide, antithymocyte globulin, with or without low dose total body irradiation, for alternative donor transplants, in acquired severe aplastic anemia: a retrospective study from the EBMT-SAA Working Party

Genetic variations in the heparanase gene (HPSE) associate with increased risk of GVHD following allogeneic stem cell transplantation: effect of discrepancy between recipients and donors

Granulocyte-colony stimulating factor for hematopoietic stem cell donation from healthy female donors during pregnancy and lactation: what do we know? ⬇️

High response rate and improved graft-versus-host disease following bortezomib as salvage therapy after reduced intensity conditioning allogeneic stem cell transplantation for multiple myeloma

Human cytomegalovirus kinetics following institution of artesunate after hematopoietic stem cell transplantation.

Immunological effects of nilotinib prophylaxis after allogeneic stem cell transplantation in patients with advanced chronic myeloid leukemia or philadelphia chromosome-positive acute lymphoblastic leukemia

Inhibition of matrix metalloproteinase-2 by halofuginone is mediated by the Egr1 transcription factor

Intravenous busulfan for autologous stem cell transplantation in adult patients with acute myeloid leukemia: a survey of 952 patients on behalf of the Acute Leukemia Working Party of the European Group for Blood and Marrow Transplantation.

Intravenous busulfan-based conditioning prior to allogeneic hematopoietic stem cell transplantation: myeloablation with reduced toxicity

Long-term outcome after a treosulfan-based conditioning regimen for patients with acute myeloid leukemia: A report from the Acute Leukemia Working Party of the European Society for Blood and Marrow Transplantation.

Minimally cultured or selected autologous tumor-infiltrating lymphocytes after a lympho-depleting chemotherapy regimen in metastatic melanoma patients

Missing HLA C group 1 ligand in patients with AML and MDS is associated with reduced risk of relapse and better survival after allogeneic stem cell transplantation with fludarabine and treosulfan reduced toxicity conditioning.

Mobilization regimens prior to stem-cell collection in patients with lymphoma: how to choose?

Modification of heparanase gene expression in response to conditioning and LPS treatment: strong correlation to rs4693608 SNP ⬇️

Monoclonal Antibody-Based Immunotherapy for Multiple Myeloma ⬇️

Non-myeloablative hematopoietic stem cell transplantation (NST) in the treatment of human malignancies: from animal models to clinical practice

Non-myeloablative stem-cell transplantation in the treatment of malignant and non-malignant disorders.

Nonmyeloablative stem cell transplantation: lessons from the first decade of clinical experience.

Novel Immunosuppression Compounds and Experimental Therapies for Chronic Graft-Versus-Host Disease ⬇️

Novel Strategies for Immunotherapy in Multiple Myeloma: Previous Experience and Future Directions ⬇️

Optimizing the conditioning regimen for allogeneic stem-cell transplantation in acute myeloid leukemia; dose intensity is still in need ⬇️

Phase I safety and pharmacokinetic study of CT-011, a humanized antibody interacting with PD-1, in patients with advanced hematologic malignancies

Prediction of Allogeneic Hematopoietic Stem-Cell Transplantation Mortality 100 Days After Transplantation Using a Machine Learning Algorithm: A European Group for Blood and Marrow Transplantation Acute Leukemia Working Party Retrospective Data [...]

Prediction of Hematopoietic Stem Cell Transplantation Related Mortality- Lessons Learned from the In-Silico Approach: A European Society for Blood and Marrow Transplantation Acute Leukemia Working Party Data Mining Study

Prospective noninterventional study on peripheral blood stem cell mobilization in patients with relapsed lymphomas

Radioimmunotherapy and Autologous Stem-Cell Transplantation in the Treatment of B-Cell Non-Hodgkin Lymphoma

Radioimmunotherapy and stem-cell transplantation in the treatment of aggressive B-cell lymphoma

Reassessing the role of high dose cytarabine and mitoxantrone in relapsed/refractory acute myeloid leukemia

Recent compounds for immunosuppression and experimental therapies for acute graft-versus-host disease

Regulatory T Cells in Allogeneic Stem Cell Transplantation ⬇️

Rituximab reduces relapse risk after allogeneic and autologous stem cell transplantation in patients with high-risk aggressive non-Hodgkin's lymphoma

Salvage therapy with ARA-C and gemtuzumab ozogamicin in AML patients relapsing after stem cell transplantation

Second allogeneic stem cell transplantation in patients with acute lymphoblastic leukaemia: a study on behalf of the Acute Leukaemia Working Party of the European Society for Blood and Marrow Transplantation.

The High-Affinity CXCR4 Antagonist BKT140 Is Safe and Induces a Robust Mobilization of Human CD34+ Cells in Patients with Multiple Myeloma ⬇️

The combination of cyclosporine and mycophenolate mofetil is less effective than cyclosporine and methotrexate in the prevention of acute graft-versus host disease after stem-cell transplantation from unrelated donors.

The expanding horizon of immunotherapy in the treatment of malignant disorders: allogeneic hematopoietic stem cell transplantation and beyond.

The impact of graft-versus-host disease prophylaxis in reduced-intensity conditioning allogeneic stem cell transplant in acute myeloid leukemia: a study from the Acute Leukemia Working Party of the European Group for Blood and Marrow Transplantation

The role of stem-cell transplantation in the treatment of marginal zone lymphoma

Thiotepa-busulfan-fludarabine compared to busulfan-fludarabine for sibling and unrelated donor transplant in acute myeloid leukemia in first remission.

Thrombotic microangiopathy after allogeneic stem cell transplantation in the era of reduced-intensity conditioning: The incidence is not reduced

Treatment of severe steroid resistant acute GVHD with mesenchymal stromal cells (MSC) ⬇️

Treatment with interferon alpha prior to discontinuation of imatinib in patients with chronic myeloid leukemia

Tumor cell contamination in re-infused stem cell autografts: does it have clinical significance?

Yttrium-90-ibritumomab tiuxetan (Zevalin) combined with high-dose BEAM chemotherapy and autologous stem cell transplantation for chemo-refractory aggressive non-Hodgkin's lymphoma